Evidence map›Paper›PMID 30789376›Full record

ArticleClinical dysmorphology2019

Rubinstein-Taybi syndrome 2 with cerebellar abnormality and neural tube defect.

Kinga Hadzsiev, Zsuzsanna Gyorsok, Agnes Till, Márta Czakó, Oliver Bartsch

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Clinical dysmorphology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Kinga HadzsievDepartment of Medical Genetics, Medical School, Clinical Center, University of Pécs, Pécs.
Zsuzsanna GyorsokDepartment of Neurology, Bethesda Children Hospital, Budapest, Hungary.
Agnes Till
Márta CzakóDepartment of Medical Genetics, Medical School, Clinical Center, University of Pécs, Pécs.
Oliver BartschInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
University of Pecs · HUGTx (United States) · USJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rubinstein-Taybi syndrome (RSTS) is a rare dominant disorder with intellectual disability, postnatal growth deficiency, and multiple congenital anomalies. Approximately 50-70% of the patients have a mutation in the CREBBP gene (RSTS1) and 5-10% display an EP300 gene mutation (RSTS2). Craniospinal abnormalities such as microcranium, scoliosis, and lordosis are frequent findings in RSTS1, but malformations of the brain or spinal cord are seen only occasionally. Here, we report on a 3-year-old boy with facial abnormalities of RSTS, broad thumbs and halluces, developmental delay, autistic features, cerebellar underdevelopment, and a neural tube defect. Molecular diagnostic of the CREBBP and EP300 genes showed a heterozygous 17-bp deletion (c.5698_5714del AAGGCAGCAGGCCAGGT) in exon 31 of the EP300 gene. Findings underline that small (hypoplastic) cerebellum and neural tube defects belong to the phenotypic spectrum not only of RSTS1 but also of RSTS2. Based on the literature and this observation, we recommend that each individual with RSTS2 should be closely evaluated for neural axis and craniovertebral junction anomalies, and where appropriate, neuroimaging studies should be considered. Our frequency estimate of ~ 6% occult or overt neural tube defects in RSTS2 could represent an underestimate.

Indexed as

CerebellumChild, PreschoolCREB-Binding ProteinE1A-Associated p300 ProteinExonsFrameshift MutationGenetic Association StudiesGenetic TestingGenome, HumanGenotypeHeterozygoteHigh-Throughput Nucleotide SequencingHumansMaleMutationNeural Tube DefectsCREB-Binding ProteinCREBBP protein, humanE1A-Associated p300 ProteinEP300 protein, human

Identifiers

PMID30789376
PMCPMC6553355
OpenAlexW2916370273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.